Delirium in palliative medicine: A review

Journal of Pain and Symptom Management

Volumn 44, Issue 4, 2012, Pages 583-594

  LeGrand, Susan B ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Antipsychotic; Delirium; Palliative medicine

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; DONEPEZIL; HALOPERIDOL; LORAZEPAM; MELATONIN; METHYLPHENIDATE; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; ZIPRASIDONE;

ALCOHOL WITHDRAWAL; ANEMIA; BEDSIDE CONFUSION SCALE; BRAIN METASTASIS; BRAIN TUMOR; CANCER PATIENT; CLINICAL EVALUATION; CLOCK DRAWING TEST; COCHRANE LIBRARY; CONFUSION ASSESSMENT METHOD; DEHYDRATION; DELIRIUM; DELIRIUM RATING SCALE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG MEGADOSE; EPILEPTIC STATE; FAMILY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERNATREMIA; HYPONATREMIA; HYPOXIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER FAILURE; MEMORIAL DELIRIUM ASSESSMENT SCALE; MINI MENTAL STATE EXAMINATION; MORBIDITY; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PNEUMONIA; RATING SCALE; RESPIRATORY FAILURE; REVIEW; URINARY TRACT INFECTION;

EID: 84869210737     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.10.013     Document Type: Review

References (123)

1. Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000;89:1145-1149.
2. Lawlor PG, Fainsinger RL, Bruera ED. Occurrence, causes and outcome of delirium in advanced cancer patients: a prospective study. Arch Intern Med 2000;160:786-794. (Pubitemid 30165239)
3. Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006;20:17-23. (Pubitemid 43224657)
4. Sarhill N, Walsh D, Nelson KA, LeGrand S, Davis MP. Assessment of delirium in advanced cancer: the use of the bedside confusion scale. Am J Hosp Palliat Care 2001;18:335-341.
5. Meagher D. Motor subtypes of delirium: past present and future. Int Rev Psychiatry 2009;21: 59-73.
6. Stagno D, Gibson C, Breitbart W. The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2004;2:171-179.
7. Meagher DJ, Trzepacz PT. Motoric subtypes of delirium. Semin Clin Neuropsychiatry 2000;5: 75-85.
8. Friedlander MM, Brayman Y, Breitbart WS. Delirium in palliative care. Oncology 2004;18: 1541-1553.
9. Fang CK, Chen HW, Liu SI, et al. Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective study. Jpn J Clin Oncol 2008;38:56-63.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. text revision, 4th ed. Washington, DC: American Psychiatric Association, 2000.
11. Lawlor PG, Bruera ED. Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002;16:701-714. (Pubitemid 34827376)
12. Bush SH, Bruera E. The assessment and management of delirium in cancer patients. Oncologist 2009;14:1039-1049.
13. O'Keeffe S, Lavan J. The prognostic significance of delirium in older hospital patients. J AM Geriatr Soc 1997;45:174-178. (Pubitemid 27066526)
14. Kaplan NM, Palmer BF, Roche V. Etiology and management of delirium. Am J Med Sci 2003;325: 20-30. (Pubitemid 36109685)
15. Maldonado Jr. Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin 2008;24: 789-856, ix.
16. Trzepacz PT. Is there a common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000;5:134-148.
17. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008;63A:764-772.
18. Tune LE. Serum anticholinergic activity levels and delirium in the elderly. Semin Clin Neuropsychiatry 2000;5:149-153.
19. Levkoff SE, Safran C, Cleary PD, et al. Identification of factors associated with the diagnosis of delirium in elderly hospitalized patients. J Am Geriatr Soc 1988;36:1099-1104. (Pubitemid 19005051)
20. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993;119: 474-481. (Pubitemid 23310108)
21. Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994;97:278-288. (Pubitemid 24284367)
22. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852-857. (Pubitemid 26087222)
23. Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:6712-6718. (Pubitemid 46190266)
24. Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006;46:1481-1486. (Pubitemid 44704208)
25. Moss JH, Lanctot KL. Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients. J Am Geriatr Soc 1998;46:1020-1022. (Pubitemid 28374085)
26. Irwin P, Murray S, Bilinski A, Chern B, Stafford B. Alcohol withdrawal an underrated cause of agitated delirium and terminal restlessness in patients with advanced malignancy. J Pain Symptom Manage 2005;29:104-108. (Pubitemid 40126230)
27. Kurita GP, Sjogren P, Elkholm O, et al. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J Clin Oncol 2011;29:1297-1303.
28. Gustafson Y, Brännström B, Norberg A, et al. Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients. J Am Geriatr Soc 1991;39:760-765.
29. Farrel KR, Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 1995;155:2459-2464.
30. Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med 2000;16:357-372. (Pubitemid 30331642)
31. Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997;13:128-137. (Pubitemid 27172870)
32. Lawlor PG, Nekolaichuk C, Gagnon B, et al. Clinical utility, factor analysis and further validation of the memorial delirium assessment scale in patients with advanced cancer. Cancer 2000;88: 2859-2867. (Pubitemid 30417951)
33. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97. (Pubitemid 18038426)
34. Trzepacz PT, Mittal S, Torres R, et al. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-242. (Pubitemid 32499675)
35. Fadul N, Kaur G, Zhang T, et al. Evaluation of the memorial delirium assessment scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals. Support Care Cancer 2007;15:1271-1276. (Pubitemid 47583448)
36. Wong CL, Holroyd-Leduc J, Simel DL, Straus SE. Does this patient have delirium? Value of bedside instruments. JAMA 2010;304:779-786.
37. Gaudreau J, Gagnon P, Harel F, Tremblay A, Roy M. Fast, systematic and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage 2005; 29:368-375. (Pubitemid 40602517)
38. Inouye SK, van Dyck, Alessi CA, et al. Clarifying confusion: the confusion assessment method. Ann Intern Med 1990;113:941-948.
39. Ryan K, Leonard M, Guerin S, et al. Validation of the confusion assessment method in the palliative care setting. Palliat Med 2009;23:40-45.
40. Adamis D, Morrison C, Treloar A, McDonald AJD, Martin FC. The performance of the clock drawing test in elderly medical inpatients: does it have utility in the identification of delirium. J Geriatr Psychiatry Neurol 2005;18:129-133. (Pubitemid 41284962)
41. Mittal V, Muralee S, Wiliamson D, et al. Delirium in the elderly; a comprehensive review. Am J Alzheimers Dis Other Demen 2011;26:97-109.
42. Cole M, McCusker J, Dendukuri N, Han L. The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003; 51:754-760. (Pubitemid 36693423)
43. Boettger S, Passik S, Breitbart W. Delirium superimposed on dementia versus delirium in the absence of dementia: phenomenological differences. Palliat Support Care 2009;7:495-500.
44. Cole MG, Ciampi A, Belzile E, Zhong L. Persistent delirium in older hospitalized patients: a systematic review of frequency and prognosis. Age Ageing 2009;38:19-26. J Am Geriatr Soc 2009;51(6): 754-760.
45. Dasgupta M, Hillier LM. Factors associated with prolonged delirium. Int Psychogeriatr 2010; 22:373-394.
46. Macullich AMJ, Beaglehole A, Hall RJ, Meagher DJ. Delirium and long-term cognitive impairment. Int Rev Psychiatry 2009;21:630-642.
47. Cole MG. Persistent delirium in older hospital patients. Curr Opin Psychiatry 2010;23:250-254.
48. Davydow DS. Symptoms of depression and anxiety after delirium. Psychosomatics 2009;50: 309-316.
49. Roth AJ, Breitbart W. Psychiatric emergencies in terminally ill cancer patients. Hematol Oncol Clin North Am 1996;10:235-259. (Pubitemid 26048357)
50. O'Keeffe ST, Lavan JN. Clinical significance of delirium subtypes in older people. Age Ageing 1999;28:115-119. (Pubitemid 29161214)
51. Kiely DK, Jones NJ, Bergman MA, Marcantonio ER. Association between psychomotor activity delirium subtypes and mortality among newly admitted postacute facility patients. J Gerontol A Biol Sci Med Sci 2007;62A:174-179. (Pubitemid 47065740)
52. Breitbart W, Givson C, Tremblay A. The delirium experience: delirium recall and deliriumrelated distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43:189-194.
53. Cohen MZ, Pace EA, Kaur G, Bruera E. Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care 2009;25: 164-171.
54. Bruera E, Bush SH, Willey J, et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 2009;115:204-212.
55. Bruera E, Fainsinger RL, Miller MJ, Kuehn N. The assessment of pain intensity in patients with cognitive failure: a preliminary report. J Pain Symptom Manage 1991;7:267-270.
56. Buffum MD, Hutt E, Chang VT, Craine MH, Snow AL. Cognitive impairment and pain management: review of issues and challenges. J Rehabil Res Dev 2007;44:315-330.
57. Brajtman S. The impact on the family of terminal restlessness and its management. Palliat Med 2003;17:454-460. (Pubitemid 36827054)
58. Morita T, Akechi T, Ikenaga M, et al. Terminal delirium: recommendations from bereaved families' experience. J Pain Symptom Manage 2007;34: 579-589. (Pubitemid 350161244)
59. Gagnon P, Charbonneau C, Allard P, Soulard C, Fillion L. Delirium in advanced cancer: a psychoeducational intervention for family caregivers. J Palliat Care 2002;18:253-261.
60. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22:997-1006. (Pubitemid 33152685)
61. Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007;6:329-339. (Pubitemid 46367947)
62. Haffey S, McKernan A, Pang K. Non-convulsive status epilepticus: a profile of patients diagnosed within a tertiary referral centre. J Neurol Neurosurg Psychiatry 2004;75:1043-1044. (Pubitemid 38869623)
63. Tabet N, Howard R. Non-pharmacological interventions in the prevention of delirium. Age Ageing 2009;38:274-379.
64. Gagnon P, Allard P, Gagnon B, Merette C, Tardif F. Delirium prevention in terminal cancer: assessment of a multicomponent intervention. Psychooncology 2012;21:187-194.
65. Inouye SK, Bogardus ST, Carpenter PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 360:669-676. (Pubitemid 29110750)
66. Tabet N, Howard R. Pharmacological treatment for the prevention of delirium: review of the current evidence. Int J Geriatr Psychiatry 2009;24: 1037-1044.
67. Overshott R, Karim S, Burns A. Cholinesterase inhibitors for delirium. Cochrane Database Syst Rev 2008;(1):CD005317.
68. Dalal S, Del Fabbro E, Bruera E. Is there a role for hydration at the end of life. Curr Opin Support Palliat Care 2009;3:72-78.
69. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol 2004;2:467-483. (Pubitemid 40100631)
70. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 1994;272: 1263-1266.
71. Lawlor PG. Delirium and dehydration: some fluid for thought. Support Care Cancer 2002;10: 445-454. (Pubitemid 36056268)
72. Galanakis C, Mayo NE, Gagnon B. Assessing the role of hydration in delirium at the end of life. Curr Opin Support Palliat Care 2011;5:169-173.
73. Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for treatment of hospital-associated delirium in medically and surgically ill patients. Ann Pharmacother 2006;40: 1966-1973. (Pubitemid 44747466)
74. Campbell N, Boustani MA, Ayub A, et al. Pharmacological management of delirium in hospitalized adults. J Gen Intern Med 2009;24:848-853.
75. Gagnon PR. Treatment of delirium in supportive and palliative care. Curr Opin Support Palliat Care 2008;2:60-66.
76. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999;156(Suppl 5):1-20.
77. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007;68:11-21. (Pubitemid 46220119)
78. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev 2007;(2):CD005594.
79. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153: 231-237. (Pubitemid 26038965)
80. Tahir TA, Eeles E, Karapareddy V, et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010;69:485-490.
81. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010;38:419-427.
82. Grover S, Mattoo SK, Gupta N. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review. Pharmacopsychiatry 2011;44:43-54.
83. Peritogiannia V, Stefanou E, Lixouriotis C, Gkogkos C, Rizos DV. Atypical antipsychotics in the treatment of delirium. Psychiatry Clin Neurosci 2009;63:623-631.
84. Boettger S, Breitbart W. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care 2005;3: 227-238.
85. Rea RS, Battisone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy 2007;27:588-594. (Pubitemid 46536239)
86. Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:297-301.
87. Mayaji S, Yamamoto K, Hoshino S, et al. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry Clin Neurosci 2007;61:275-282. (Pubitemid 46683993)
88. Liu CY, Juang YY, Liang HY, Lin NC, Yeh EK. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004;19:165-168.
89. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs. haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004;30:444-449. (Pubitemid 38375619)
90. Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998;39: 422-430. (Pubitemid 28439942)
91. Boettger S, Friedlander M, Breitbart W, Passik S. Aripiprazole and haloperidol in the treatment of delirium. Aust N Z J Psychiatry 2011;45: 477-482.
92. Mittal D, Jimerson NA, Neely EP, et al. Risperidone in the treatment of delirium: results from a prospective open-labeled trial. J Clin Psychiatry 2004;65:662-667.
93. Horikawa N, Yamazaki T, Miyamoto K, et al. Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003;25:289-292. (Pubitemid 36802275)
94. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43:175-182. (Pubitemid 34522527)
95. Kim SW, Yoo JA, Lee SY, et al. Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 2010;25:293-302.
96. Sasaki Y, Matsuyama T, Inoue S, et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003;64:1316-1321. (Pubitemid 37490236)
97. Aloa A. Aripiprazole and delirium. Ann Clin Psychiatry 2006;18:267-269.
98. Straker DA, Shaprio PA, Muskin PR. Aripiprazole in the treatment of delirium. Psychosomatics 2006;47:385-391.
99. Young C, Lujan E. Intravenous ziprasidone for treatment of delirium in intensive care unit. Anesthesiology 2004;101:794-795. (Pubitemid 39121662)
100. Leso L, Schwartz T. Ziprasidone treatment of delirium. Psychosomatics 2002;43:61-62. (Pubitemid 34214164)
101. Samuels S, Fang M. Olanzapine may cause delirium in geriatric patients. J Clin Psychiatry 2004; 65:582-583.
102. Lim CJ, Trevino C, Tampi RR. Can olanzapine cause delirium in the elderly? Ann Pharmacother 2005;40:135-138.
103. Tavcar R, Dernovsek MZ. Risperidone-induced delirium. Can J Psychiatry 1998;43:194.
104. Kato D, Kawanishi C, Kisida I, et al. Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype. Psychosomatics 2005;46:374-375. (Pubitemid 41472639)
105. Elsayem A, Bush SH, Munsell MF, et al. Subcutaneous olanzapine for hyperactive or mixed delirium in patient with advanced cancer: a preliminary study. J Pain Symptom Manage 2010;40:774-782.
106. Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 2011;40:23-29.
107. Lonergan E, Luxenberg J, Sastre AA. Benzodiazepines for delirium. Cochrane Database Syst Rev 2009;(4):CD006379.
108. Agar M, Currow DC, Plummer J, Chye R, Draper B. Differing management of people with advanced cancer and delirium by four sub-specialties. Palliat Med 2008;22:633-640.
109. Canadian Coalition for Senior's Mental Health. National guidelines for senior's mental health: The assessment and treatment of delirium. Toronto, Canada: Canadian Coalition for Senior's Mental Health, 2006. Available from http://www. ccsmh.ca/en/download.cfm.
110. Platt MM, Breitbart W, Smith M, et al. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994;6:66-67.
111. Morita T, Otani H, Tsunoda J, Inoue S, Chihara S. Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer 2000;8:134-137. (Pubitemid 30114822)
112. Keen JC, Brown D. Psychostimulants and delirium in patients receiving palliative care. Palliat Support Care 2004;2:199-202.
113. Gagnon B, Low G, Schreier G. Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci 2005;30:100-107.
114. Hui D, Bush SH, Gall LE, Palmer JL, Yennurajalingam S. Neuroleptic dose in the management of delirium in patients with advanced cancer. J Pain Symptom Manage 2010;39:186-196.
115. Fainsinger RL, De Moissac D, Mancini I, Oneschuk D. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000;16:5-10.
116. Burke E, Diamond PL, Hulbert J, Yeatman J, Farr EA. Terminal restlessness: its management and the role of midazolam. Med J Aust 1991;155: 485-487.
117. Kehl KA. Treatment of terminal restlessness: a review of the evidence. J Pain Palliat Care Pharmacother 2004;18:5-30. (Pubitemid 38747715)
118. Del Fabbro ED, Reddy SG, Walker P, Bruera E. Palliative sedation: when the family and consulting service see no alternative. J Palliat Med 2007;10: 488-492. (Pubitemid 46740224)
119. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan. The importance of intermittent use and communication with family members. J Pain Symptom Manage 1996;12:32-38. (Pubitemid 26187522)
120. Ventifridda V, Ripamonti C, de Conno F, et al. Symptom prevalence and control during cancer patients last days of life. J Palliat Care 1990;6:32-38.
121. Fainsinger RL, Waller A, Bercovici M, et al. A multi-centre international study of sedation for uncontrolled symptoms. Palliat Med 2000;4: 257-265. (Pubitemid 30609544)
122. Cowan JD, Walsh D. Terminal sedation in palliative medicine-definition and review of the literature. Support Care Cancer 2001;9:403-407. (Pubitemid 32843627)
123. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994;9:341-345. (Pubitemid 24241429)